PCOS and Semaglutide: Side Effects and Safety The most common side effects in PCOS patients are nausea (30-40% of users), constipation, and reduced appetite for foods they previously enjoyed
Veru press release, 28 May 2025: Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone Rivus Pharmaceuticals press release, 30 September 2024: Regeneron press release, 2 June 2025: Interim Results from Ongoing Phase 2 COURAGE Trial Confirm Potential to Improve the Quality of Semaglutide (GLP-1 receptor agonist)-induced Weight Loss by Preserving Lean Mass | Regeneron Pharmaceuticals Inc
Environmental Exposure : People exposed to heavy metals, chemicals, or air pollution may benefit from improved detoxification support
Slower dose titration can minimize metabolic stress
Here is what shes found so far: Nutrition for bariatric patients and patients on GLP-1 medications is almost entirely the same